Pursuant to Regulation 44(3) of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 please find enclosed the Scrutinizer''s Report on the business transacted through ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Pharma Industries Ltd has submitted the Scrutinizer's Report for a Postal Ballot conducted to approve the appointment of Dr. Vijay Ojha (DIN: 02216129) as a Non-Executive, Independent Director of the Company. The Postal Ballot Notice was sent on December 11, 2025, with e-voting conducted from December 15, 2025 to January 13, 2026 via NSDL. The cut-off date for voting eligibility was December 5, 2025, with 7,447 shareholders on record. The special resolution was passed with the requisite majority, as confirmed by Scrutinizer Vishal N. Manseta, Practicing Company Secretary.
Dr. Vijay Ojha is now confirmed as a Non-Executive Independent Director on the board. This is a routine governance update with no material financial impact, but strengthens the board's independent oversight for shareholders.